Scotia Capital Inc. increased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 3.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 188,819 shares of the technology company's stock after acquiring an additional 5,608 shares during the period. Scotia Capital Inc.'s holdings in Relx were worth $8,577,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in RELX. Private Trust Co. NA grew its stake in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after buying an additional 199 shares in the last quarter. Sage Mountain Advisors LLC raised its holdings in shares of Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock valued at $240,000 after buying an additional 258 shares during the last quarter. DRW Securities LLC grew its position in Relx by 5.9% in the 4th quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after buying an additional 259 shares during the last quarter. Peapack Gladstone Financial Corp lifted its holdings in shares of Relx by 5.7% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock valued at $234,000 after buying an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc grew its holdings in shares of Relx by 1.3% in the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock worth $1,190,000 after acquiring an additional 325 shares during the period. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts have commented on the stock. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. The Goldman Sachs Group initiated coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating on the stock. Redburn Atlantic assumed coverage on Relx in a research note on Wednesday, January 8th. They set a "buy" rating for the company. Finally, StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy".
Read Our Latest Research Report on Relx
Relx Stock Performance
RELX traded up $0.19 during midday trading on Wednesday, reaching $51.70. The company's stock had a trading volume of 306,636 shares, compared to its average volume of 717,166. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The stock has a market cap of $95.69 billion, a P/E ratio of 27.80, a PEG ratio of 2.73 and a beta of 0.84. The company has a fifty day simple moving average of $49.30 and a 200 day simple moving average of $47.91.
Relx Increases Dividend
The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is an increase from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. Relx's dividend payout ratio is currently 59.68%.
Relx Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Featured Articles
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
